Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AZN compared with PFE: revenue, margins and what each company keeps, and the suppliers and customers both name
AZN
Astrazeneca PLC
Change
Mkt cap
Revenue
Revenue
PFE
Pfizer Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
AZN
Astrazeneca PLC
vs
PFE
Pfizer Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
AZN
No earnings history for AZN.
PFE
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±3.7%
▼
−2.18%
×0.59
Q2 FY26
±3.3%
▲
+1.52%
×0.45
Q1 FY26
±3.5%
▲
+0.57%
×0.17
Feb 3 '26
±3.2%
▼
−3.34%
×1.03
= implied
AZN realized, solid
PFE realized, hatched
One scale, both sides: full bar = 4%
× = |realized| ÷ implied
Source: market data
AZN
Astrazeneca PLC
Change
186.20
▼
−0.35%
· post 187.60
Mkt cap
$289.1B
Revenue
—
Revenue
—
PFE
Pfizer Inc
Change
29.39
▼
−0.21%
· post 29.35
Closed
Nov 6 '26
Mkt cap
$167.5B
Revenue
$16.6B
Q3 FY26
Revenue
$62.6B
FY25
vs
Compare
Closed
Nov 6 '26
AZN
Astrazeneca PLC
vs
PFE
Pfizer Inc
186.20
▼
−0.35%
post 187.60
Price
29.39
▼
−0.21%
post 29.35
$289.1B
Mkt cap
$167.5B
—
Revenue
$16.6B
Q3 FY26
—
Revenue
$62.6B
FY25
Change
Change
AZN
186.20
▼
−0.35%
vs
PFE
29.39
▼
−0.21%
Closed
Nov 6 '26